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*S Supporting Information
ABSTRACT: pH-responsive lipid nanocarriers have the
potential to selectively target the acidic extracellular pH
environment of cancer tissues and may further improve the
eﬃcacy of chemotherapeutics by minimizing their toxic side-
eﬀects. Here, we present the design and characterization of
pH-sensitive nano-self-assemblies of the poorly water-soluble
anticancer drug 2-hydroxyoleic acid (2OHOA) with glycerol
monooleate (GMO). pH-triggered nanostructural trans-
formations from 2OHOA/GMO nanoparticles with an
internal inverse hexagonal structure (hexosomes) at pH
around 2.0−3.0, via nanocarriers with an internal inverse
bicontinuous cubic structure (cubosomes) at pH 2.0−4.5, to
vesicles at pH 4.5−7.4 were observed with synchrotron small-
angle X-ray scattering, and cryogenic transmission electron microscopy. ζ-potential measurements highlight that the pH-driven
deprotonation of the carboxylic group of 2OHOA, and the resulting charge-repulsions at the lipid−water interface account for
these nanostructural alterations. The study provides detailed insight into the pH-dependent self-assembly of 2OHOA with
GMO in excess buﬀer at physiologically relevant pH values, and discusses the eﬀects of pH alterations on modulating their
nanostructure. The results may guide the further development of pH-responsive anticancer nanocarriers for the targeted
delivery of chemotherapeutics to the local microenvironment of tumor cells.
■ INTRODUCTION
Cancer is one of the major public health problems world-
wide.1−3 Along with the current cancer therapies, including
surgical intervention and radiation therapy, chemotherapy is
characterized as the least invasive cancer treatment approach
with a clinical success in tumor shrinking and cancer relapse
reduction.4−6 However, chemotherapy is often associated with
side-eﬀects caused by the oﬀ-site toxicity due to the lack of
drug speciﬁcity.5 Hence, the design of novel and more eﬃcient
cancer nanomedicines that can selectively target the tumor
sites, avoiding oﬀ-target side-eﬀects, may improve current
therapies and also patients’ quality of life.5,7−10 Among
diﬀerent suggested nanomedicines, pH-triggered chemother-
apeutic delivery systems may be of interest in cancer treatment,
as the extracellular microenvironment of tumor cells with pH
of around 5.5−6.5 is more acidic than that of healthy cells with
pH of 7.4.10−12 The occurrence of such acidic local tumor
microenvironment is attributed to an increased glycolysis rate,
a higher production level of lactic acid, and an insuﬃcient
vasculature for the removal of acidic byproducts.11,13−18
This study describes the formation and characterization of
pH-responsive self-assembled nanocarriers based on glycerol
monooleate (GMO), and the anticancer drug 2-hydroxyoleic
acid (2OHOA). The molecular structures of both lipids are
presented in Figure 1. The poorly water-soluble anticancer
drug 2OHOA is a derivative of oleic acid (OA) with an
additional hydroxyl group on the α-carbon of the fatty acid
backbone.19 It is a potent anticancer agent that induces cell
Figure 1. Molecular structures of the lipids: (A) glycerol monooleate
(GMO) and (B) 2-hydroxyoleic acid (2OHOA). The carboxylic
group of 2OHOA is highlighted in red color in panel B.
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cycle arrest and apoptosis, cellular diﬀerentiation, and
autophagy in a wide range of human cancer cells, including
leukemia, glioma, lung, colon, and breast cancer cells.19−27
GMO-based nanocarriers have been previously used for
enhancing the solubilization of poorly water-soluble therapeu-
tic agents.28−35 Among these nanocarriers, dispersions of
inverse bicontinuous cubic, hexagonal, and micellar cubic
structures (cubosomes, hexosomes, and micellar cubosomes,
respectively), emulsiﬁed microemulsions, vesicles, and sponge
phases are gaining increasing attention for their drug delivery
applications. The biological relevance and the relatively large
extent of the internal lipid−water interfacial area render these
colloidal nanosystems attractive for delivering hydrophilic,
hydrophobic, and amphiphilic drugs and peptide mole-
cules.36−48 For targeted delivery applications, they can be
surface nanoengineered to respond to an external stimulus,
such as pH, for triggering the release of therapeutic molecules
or enhancing the interactions with cells on demand, owing to
structural alterations in these nanocarriers.33,49−55 Despite the
attractiveness of cubosomes, hexosomes, and related non-
lamellar liquid crystalline nanoparticles in the development of
injectable drug nanocarriers, there is still to date no FDA-
approved formulation based on these nanostructured emul-
sions.56,57 Nevertheless, recent in vivo studies showed that
these nanoparticles are promising candidates in the develop-
ment of nanocarriers for anticancer drug delivery.58,59
The major goal of this study is to investigate the
composition and pH dependence of 2OHOA/GMO nano-
self-assemblies and gain further insight into their pH-triggered
structural, morphological, and size alterations by using
synchrotron small-angle X-ray scattering (SAXS), cryogenic
transmission electron microscopy (cryo-TEM), and ζ-potential
measurements. An improved understanding of the structural
mechanism involved in these pH-triggered transitions is an
important keystone toward the development of pH-responsive
anticancer nanomedicines. Based on the presented exper-
imental ﬁndings, the pH-induced phase transformations in the
interiors of 2OHOA/GMO nanoparticles are most likely
attributed to the protonation/deprotonation of the carboxylic
group of 2OHOA at the lipid−water interface. The presented
results shed light on the molecular interactions during the self-
assembly of a cell membrane active anticancer agent with a
biologically relevant lipid in excess buﬀer and could potentially
be applied for the future design of pH-guided nanocarriers for
tumor-targeted delivery of anticancer drugs.
■ EXPERIMENTAL SECTION
Preparation of 2OHOA/GMO Nanodispersions. Sodium salt
of 2-hydroxyoleic acid (2OHOA; Avanti polar lipids, Alabama,
U.S.A.) and glycerol monooleate (GMO; ≥90% purity, Riken Vitamin
co., Ltd. company, Japan) were weighed out in glass vials at 3/7 and
1/1 2OHOA/GMO mass ratios and dispersed in 149 mM Dulbecco’s
Phosphate-buﬀered saline (PBS) at pH 7.4 (Sigma-Aldrich, Poole,
UK), containing 2 mg/mL Pluronic F127 (gift from BASF SE,
Ludwigshafen, Germany), to achieve a total lipid concentration of 20
mg/mL. These raw lipid emulsions were then homogenized by means
of ultrasonication (Ultrasonic Processor Qsonica 500, Qsonica LLC,
Newtown, CT, U.S.A.) for 4 min in pulse mode (3 s pulse, 5 s break)
at 27% of its maximum power (500 W). The pH of the prepared
nanodispersions was then adjusted with 1 M NaOH (≥99% purity,
Carl Roth GmbH, Karlsruhe, Germany) or 1 M HCl prepared from
37% HCl stock solution (ACS reagent grade, Sigma-Alrdich, Buchs,
Switzerland) and allowed to equilibrate at 25 °C for at least 1 h before
carrying out the planned experiments. In this study, the pH of the
continuous aqueous medium of the dispersion with 1/1 2OHOA/
GMO mass ratio was ﬁrst gradually decreased from 7.4 to 2.0 and
then increased back to 5.0, while taking out samples at diﬀerent
selected pH points for SAXS structural characterization. This pH
cycle was applied to study whether the structural alterations
associated with changing pH can be reversed. Double distilled
water was used for the preparation of all samples. All ingredients were
used without further puriﬁcation.
Synchrotron Small-Angle X-ray Scattering (SAXS). SAXS
patterns were recorded at the Austrian SAXS beamline at the
synchrotron light source ELETTRA (Trieste, Italy). An X-ray beam
with a wavelength of 1.54 Å (8 keV) was used, with a sample-to-
detector distance of 1314 mm, covering a q-range from about 0.18 to
5.00 nm−1, where q is the length of the scattering vector, deﬁned by q
= 4π/λ sin(θ/2), λ being the wavelength, and θ the scattering angle.
The samples were sealed in thin-walled quartz capillaries and ﬁve
frames with an exposure time of 20 s per frame were collected and
averaged at room temperature. The 2D SAXS patterns were acquired
using a Pilatus3 1 M detector (Dectris Ltd., Baden, Switzerland; active
area 169 × 179 mm2 with a pixel size of 172 × 172 μm2), integrated
into one-dimensional (1-D) scattering function I(q) using Fit2D60
(European Synchrotron Radiation Facility, Grenoble, France) and
then analyzed with IGOR pro (Wavemetrics, Inc., Lake Oswego,
U.S.A.). The scattering curves were plotted as a function of intensity,
I(q), averaged over the ﬁve repeated exposures versus q. The
scattering from PBS was subtracted as background from all
measurements before further data analysis. The calculation of the
lattice parameters of the corresponding lyotropic nonlamellar liquid
crystalline phases is described in SI (eqs S2−S4).
Cryogenic-Transmission Electron Microscopy (cryo-TEM).
The morphological characterization of F127-stabilized 2OHOA/
GMO nanoparticles was done in their vitriﬁed states by cryo-TEM
imaging. Brieﬂy, lacey carbon 300 mesh copper grid (Ted Pella Inc.,
CA, U.S.A.) enforced by a silicon monoxide coating was subjected to
glow discharge treatment and treated with 3 μL of the sample. The
excess sample on the grid was then blotted with ﬁlter paper at a
blotting time of 3.5 s, a blotting force 0, temperature 25 °C, and 100%
humidity (FEI Vitrobot IV, Holland) and was rapidly plunged into
liquid nitrogen-cooled ethane close to its melting point (−174 °C). A
Gatan 626 cryo-holder (Gatan, U.K.) was used to transfer the plunged
grid with the samples in a frozen glassy state into the Tecnai G2 20
transmission electron microscope (FEI, Holland). The images were
digitally recorded at a voltage of 200 kV, under low-dose conditions
(∼5 e/Å2s), and at a magniﬁcation of ×29 000.
ζ-Potential Measurements. The ζ-potential of the 2OHOA/
GMO nanodispersions was measured at diﬀerent pH using Zetasizer
Nano ZS equipped with a 633 nm laser (Malvern Instruments,
Worcestershire, U.K.). Prior to measurements at 25 °C and 173°
scattering angle, the samples were diluted 1/100 in PBS and their pH
was readjusted. ζ-potential was calculated by Zetasizer Software 7.11
(Malvern Instruments) using Smoluchowski equation:61
μ ε ε ζ
η
=e
r 0
(1)
where μe is the electrophoretic mobility, εr is the dielectric constant of
water, εo is the permittivity of vacuum, and η is the viscosity of the
solvent (water). The measurements were done in triplicate and
averaged. Estimations of 2OHOA’s pKa
app from the ζ-potential values
are described in the SI.
■ RESULTS AND DISCUSSION
The GMO dispersed in water forms cubosomes with an
internal bicontinuous cubic phase of the Pn3m or Im3m type
symmetry depending on the F127 stabilizer concentration.62,63
The integration of the anticancer drug 2OHOA into this
dispersion led to composition- and pH-dependent nano-
structural transformations in the nanocarriers. Figure 2
demonstrates the pH-dependent self-assembly of the binary
2
htt
p:/
/do
c.r
ero
.ch
2OHOA/GMO self-assemblies in excess buﬀer at a mass ratio
of 1/1. The appearance of three dominating Bragg reﬂections
in the SAXS curves at q values of 1.26, 2.17, and 2.51 nm−1,
corresponding to a peak spacing-ratio of 1:√3:√4, indicate
the formation of hexosomes with an inverse hexagonal (H2)
phase at pH 2.0. The corresponding lattice parameter, aH2, is
5.8 nm. Additional weak reﬂections, occurring most prom-
inently around q ≈ 1.1 nm−1, indicate a coexisting
bicontinuous cubic structure with Pn3m symmetry having a
lattice parameter, aPn3m, of 8.0 nm. These results demonstrate
that the 2OHOA mostly integrates into the hydrophobic
domains of the self-assembled nanostructure at pH 2.0. This
integration increases the apparent volume of the hydrophobic
domains, which ultimately leads to the nanostructural
transition from cubosomes to hexosomes. This observation
agrees with theoretical considerations from the critical packing
parameter model (see SI). The trend is also consistent with
2OHOA-induced lamellar-nonlamellar structural transitions in
dielaidoylphosphatidylethanolamine dispersion.24,64
Upon increasing the pH from 2.0 to 3.0, the Bragg peaks of
the H2 phase shifted to lower q values, corresponding to an
increase in aH2 to 5.9 nm (Figure 2). In addition to the
characteristic reﬂections of the H2 phase, additional Bragg
peaks with peak-ratios of √2:√3:√4:√6:√8:√9 were
detected. These peaks could be indexed as the (110), (111),
(200), (211), (220), and (221) reﬂection of the bicontinuous
Pn3m-type cubic structure with aPn3m = 8.3 nm. In this phase
assignment, it should be noted that the characteristic reﬂection
(220) of the cubic Pn3m phase at pH 2.0 and 3.0 appears to
overlap with the characteristic reﬂection (11) of the coexisting
H2 phase. A single peak around q ≈ 0.8 nm−1 was also
observed, likely resulting from traces of a coexisting Im3m-type
bicontinuous cubic structure. The identiﬁcation of this
coexisting Im3m structure was based on its gradual evolvement
with a further increase in pH. At pH 3.5, the Bragg reﬂections
of the H2 phase diminished and peaks indicating a coexistence
of Pn3m and Im3m phase were observed. The corresponding
lattice parameters for the biphasic Pn3m/Im3m feature were
9.1 and 12.0 nm, respectively. Further increase in pH to 4.0
caused a shift in the peak positions of the Pn3m and Im3m
phases to lower q values, resulting in an increase in aPn3m to 9.9
nm and aIm3m to 12.9 nm. At pH 4.5, the lattice parameters of
Pn3m and Im3m increased to 12.3 and 15.3 nm, respectively.
The ratio of aIm3m/aPn3m was calculated and found to be 1.32,
1.30, and 1.24 at pH 3.5, 4.0, and 4.5. This ratio is consistent
with the reported theoretical Bonnet ratio of 1.279 for these
structures36,65 (Table S1). At pH 5.0 and 6.0, two Bragg peaks
at q values of about 1.56 and 3.12 nm−1 were observed,
showing the formation of multilamellar vesicles (MLVs) with
an interlamellar d-spacing of about 4.0 nm, in agreement with
the previously reported bilayer dimensions in GMO-based self-
assemblies.66,67 At pH 7.4, the diﬀuse-dominating scattering
patterns indicated the formation of unilamellar vesicles
(ULVs). The additional broad correlation peaks in the low-q
region of the SAXS curves at pH 6.0 and 7.4, with maxima
around q ≈ 0.45 and 0.90 nm−1 are most likely attributed to
weak bilayer correlations in a coexisting population of swollen
bi- or multilamellar vesicles with an estimated d of around ∼14
nm. The formation of highly swollen lamellar structures with
similar bilayer-to-bilayer spacing and low repeat numbers was
also previously reported for nano-self-assemblies of GMO with
the anionic phospholipid dioleoyl-phosphatidylglycerol.67
To evaluate the potential to reverse the colloidal trans-
formations in this system, the pH in the sample at 1/1
2OHOA/GMO mass ratio was decreased from pH 7.4, where
vesicles were the dominating species, to pH 2.0 where
cubosomes and hexosomes dominated (Figure 2). The
following pH increase to 5.0 in this sample led to the
reformation of vesicles, demonstrating the pH-induced trans-
formations from nonlamellar structures to vesicles and back
upon circulating the pH of the continuous water phase. The
pH-triggered swelling of nonlamellar liquid crystalline
structures and the gradual nonlamellar-lamellar transitions
have been previously reported for self-assemblies containing
the analogue OA50,52,69,70 and other fatty acids.49,71
The cryo-TEM images of the 2OHOA/GMO nano-self-
assemblies at 1/1 mass ratio conﬁrmed the pH-triggered
nanostructural transitions observed by SAXS. Hexosomes were
observed at pH 2.0, and internally structured nanoparticles
coexisting with vesicles were found at pH 4.0 (Figure 3A,B). At
pH 6.0, the cryo-TEM image (Figure 3C) indicated the
Figure 2. SAXS patterns for the F127-stabilized nano-self-assemblies
prepared at 2OHOA/GMO mass ratio of 1/1 as the pH of the
dispersion was gradually decreased from 7.4 to 2.0 (red curves) and
then increased back to 5.0 (black curves). The characteristic Bragg
peaks and the corresponding Miller indices of the cubic Pn3m (red),
Im3m (black), and H2 (blue) phases are marked with arrows. Low
intensity peak attributed to a potential coexistence of Im3m phase is
marked with a black asterisk at pH 3.0. The ﬁrst two Bragg reﬂections
from the interlamellar distance of the MLVs are marked with Lα(h=1)
and Lα h=2) (green). Broad correlation peaks most likely correspond-
ing to weak bilayer correlations in a coexisting population of swollen
MLVs are marked with green asterisks.
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presence of MLVs coexisting with smaller ULVs. The image at
pH 7.4 (Figure 3D) was dominated by ULVs mostly below
100 nm in diameter, coexisting with bilamellar vesicles. The
bilayer-to-bilayer distance of around 10 nm in the cryo-TEM of
multilamellar vesicles at pH 7.4 (Figure 3D) correlates
reasonably well with the estimated interlamellar distance
from SAXS (Figure 2).
Figure 4 shows the SAXS patterns for the 2OHOA/GMO
nano-self-assemblies at a 2OHOA/GMO mass ratio of 3/7, in
the pH range of 2.0−7.4. At pH 2.0, the SAXS curve shows the
characteristic peak-spacing of the Pn3m type cubic phase with
aPn3m of 8.39 nm. Hence, compared to the dispersion that was
prepared at a mass ratio of 1/1, the 2OHOA content in this
sample is insuﬃcient to induce a Pn3m-to-H2 phase transition
even at pH 2.0. On increasing pH to 3.0 and 3.5, the calculated
lattice parameter of the cubic Pn3m phase increased to 8.6 and
9.3 nm, respectively. However, three additional Bragg peaks at
q values of 0.72, 1.02, and 1.25 nm−1 with peak spacing-ratio of
√2:√4:√6 were observed at pH 3.5, which can be attributed
to a coexisting Im3m phase with aIm3m of 12.3 nm. The
calculated ratio between the lattice parameters of Im3m and
Pn3m phases was 1.33 and fairly consistent with the theoretical
Bonnet ratio (Table S1). The SAXS curve at pH 4.0 was
dominated by the Im3m phase with aIm3m of about 14.6 nm, as
the three Im3m peaks were shifted to lower q values. Further
increase in pH to 4.5−7.4 led to the loss of the highly ordered
nonlamellar structures and the appearance of diﬀusive SAXS
curves, indicating a transformation to vesicles. The correlation
peaks observed in the low-q region of curves at pH 6.0 and 7.4,
with their maxima around 0.48 and 0.96 nm−1, may correspond
to the weak bilayer correlations of a coexisting population of
highly swollen MLVs with an estimated d of around 13 nm in
agreement with the discussions above.
The structural transformations of the 2OHOA/GMO nano-
self-assemblies upon increasing pH from 2.0 to 7.4 are
attributed to the charge repulsions between the gradually
deprotonating carboxylic groups of 2OHOA embedded at the
lipid−water interface. Such repulsions would increase the
eﬀective headgroup area of the embedded 2OHOA molecules
at the lipid−water interface, modifying its spontaneous
curvature. Figure 5 summarizes the pH-induced phase
transitions and changes in the lattice parameters for all phases
detected on increasing pH from 2.0 to 4.5 for both 2OHOA/
GMO samples prepared at mass ratios of 3/7 and 1/1. The
cubic Im3m phases in both 2OHOA/GMO dispersions
summarized in Table S1 have smaller lattice parameters at
pH 3.0 and 3.5 than pristine GMO cubosomes with aIm3m =
13.1 nm around the same pH (see Figure S1). This is
consistent with the integration of 2OHOA into the hydro-
phobic domains of the structure at this pH value. On the other
hand, upon reaching pH 4.0 and 4.5 in dispersions with
2OHOA/GMO mass ratios of 3/7 and 1/1, respectively, the
aIm3m was found to be greater than that of GMO cubosomes in
Figure 3. Representative cryo-TEM images of the nanodispersions
prepared at 2OHOA/GMO mass ratio of 1/1 and the following pH:
(A) pH 2.0, (B) pH 4.0, (C) pH 6.0, and (D) pH 7.4. The insert in
panel A shows the fast Fourier transformation (FFT) applied to the
structured part of the image indicating the formation of hexosomes.
Colloidal transitions from (A) hexosomes to (B) cubosomes, and (C)
MLVs (marked with black arrows) coexisting with relatively small
nano-self-assemblies were observed with increasing pH. Small ULVs
of variable sizes from around 100 to 15 nm in diameter were observed
at pH 7.4, coexisting with multilamellar vesicles (marked with black
arrows) with a bilayer-to-bilayer distance of around ∼10 nm (D). Figure 4. SAXS patterns of the F127-stabilized nanoself-assemblies
prepared at 2OHOA/GMO mass ratio of 3/7 and pH in the range of
2.0−7.4. The Bragg peaks of the cubic Pn3m and Im3m phases and
their corresponding Miller indices are indicated with red and black
arrows, respectively. Low intensity peaks potentially from a coexisting
Im3m phase are marked with black asterisks at pH of 2.0 and 3.0.
Broad correlation peaks, most likely corresponding to the weak bilayer
correlations in coexisting swollen MLVs, are marked with green
asterisks at pH 6.0 and 7.4.
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absence of 2OHOA (Figure S1). The later dispersion,
measured as control, showed only a slight structural alteration
in response to pH change between 3.0 and 7.0. The increase in
aIm3m from 13.1 nm at pH 3.0 to 13.5 nm at pH 7.0 may be
attributed to the potential presence of trace concentrations of
OA as a hydrolysis product in the sample.68 However, this
change in lattice parameter in the 2OHOA free cubosomes is
insigniﬁcant compared to that in the 2OHOA/GMO system
reported above. The larger pH-induced increase in the lattice
parameters of the internal liquid crystalline phases of the
2OHOA/GMO nanocarriers at pH 4.0−4.5, as compared to
that at pH 3.0−3.5, reﬂected a higher degree of 2OHOA
deprotonation and indicated the closer proximity to the
apparent pKa (pKa
app) of the embedded 2OHOA (Table S1).
Upon increasing the pH to >5.0, the 2OHOA/GMO
cubosomes eventually transformed into vesicles.
The pH eﬀect on the ζ-potential of 2OHOA/GMO nano-
self-assemblies is demonstrated in Figure 6. At pH 2.0, the
measurements for the dispersions with 1/1 and 3/7 2OHOA/
GMO mass ratios indicated the occurrence of rather neutral
surfaces with ζ-potential values of −0.4 ± 0.7 and −3.8 ± 2.9
mV, respectively. The ζ-potential of these dispersions was
observed to gradually decrease upon increasing pH, with the
largest drop in ζ-potential occurring around pH 6.0, and
reaching −30.9 ± 4.8 and −29.1 ± 3.5 mV at pH 9.0 for the
samples with 1/1 and 3/7 2OHOA/GMO mass ratios,
respectively. This decrease in ζ-potential is mostly caused by
the deprotonation of 2OHOA, and correlated well with the
discussed nanostructural transitions observed by SAXS and
cryo-TEM.
For the system at 2OHOA/GMO mass ratio of 1/1, the
decrease in the ζ-potential from −5.8 ± 2.8 to −31.3 ± 1.7 mV
on increasing pH from 5.0 to pH 7.5 could be associated with
an increase in the electrostatic repulsions between the
negatively charged 2OHOA/GMO bilayers in the MLVs.
This charge repulsion between bilayer sheets could then
induce the formation of the swollen MLVs with bilayer−
bilayer distances above 10 nm at pH 6.0 and 7.4, as reported
above.
The pKa
app values of 2OHOA in the nano-self-assemblies at
2OHOA/GMO mass ratios of 1/1 and 3/7 were calculated
from the pH-dependent ζ-potential values (see Figure 6 and
SI). The resulting pKa
app values are 6.1 ± 0.1 and 5.7 ± 0.2,
respectively. These pKa
app values are slightly larger than the
previously reported pKa
app of 5.4 for 2OHOA in Triton X-100
micelles.64 This may be caused by the diﬀerent 2OHOA
content in the 2OHOA/GMO nano-self-assemblies
(2OHOA/lipid mass ratios of 1/1 and 3/7) as compared to
a mass ratio 1/9 in 2OHOA/Triton X-100 micelles. The
higher concentration of ionizable carboxylic groups on the oil−
water interface increases the negative surface-charge density,
which could enhance the accumulation of protons, leading to
an increase in pKa
app.52,72 The results suggest that the pKa
app of
2OHOA in the designed 2OHOA/GMO nanocarriers may be
controlled through changes in the lipid composition. This
could potentially be used to tune the phase boundaries of these
self-assemblies to desired pH ranges for speciﬁc delivery
applications.
The detected pH-triggered structural transformations in this
study can be of interest in the development of 2OHOA/GMO
nanocarriers for tumor-targeted delivery applications. In the
investigated nanocarriers, the major changes in the protonation
state of 2OHOA occurred within the typical pH range of the
extracellular tumor environment of pH 5.5−6.5.11,12 The
modiﬁcations of the 2OHOA/GMO ratio in these nanocarriers
was further found to modulate the pKa
app of 2OHOA. Thus, the
nanocarriers could be ﬁne-tuned to obtain pH-triggered phase
transitions at speciﬁc pH values by optimizing the lipid
composition. Additionally, the introduction of hydrophobic
additives, such as vitamin E or triglycerides, could increase the
hydrophobic tail volume.73−78 This could also shift the phase
boundaries between cubosomes and vesicles to higher pH
values, even close to the physiological pH of 7.4. The reported
pH-triggered nanostructural transformations could also trigger
Figure 5. pH-dependent changes in the lattice parameters of the H2
(■), Pn3m (●), and Im3m (▲) phases as derived from SAXS
patterns of the two samples prepared at 1/1 (red) and 3/7 (blue)
2OHOA/GMO mass ratios presented in Figures 2 and 4. For
numerical values see Table S1.
Figure 6. pH-dependent ζ-potential values for the dispersions
prepared at 1/1 (red) and 3/7 (blue) 2OHOA/GMO mass ratios.
Fits of eq S5 to the data (see SI) are represented as lines and used to
estimate the apparent pKa of 2OHOA in the samples prepared at two
diﬀerent lipid compositions.
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speciﬁc interactions of the nanocarriers with the cells, similar
to previous observations on antimicrobial peptide nano-
carriers.70 This would improve the targeted delivery of this
anticancer agent and may focus its exposure to the acidic
tumor microenvironment, minimizing oﬀ-target side-eﬀects.
Further in vitro and in vivo studies are required to determine
the practical application of these nano-self-assemblies in cancer
therapy.
■ CONCLUSIONS
The design and characterization of pH-responsive nanocarriers
based on mixtures of 2OHOA with GMO are presented. In a
concentration and pH dependent manner, 2OHOA was found
to actively participate and modulate the structural features of
GMO dispersion. The protonation state of the embedded
2OHOA at the lipid−water interfacial area dictated the
structural and morphological characteristics of 2OHOA/
GMO nanocarriers. At pH <4.0, the mostly protonated
2OHOA integrated into the hydrophobic domains of the
cubosomes, shrinking their internal channel dimensions and
promoting the formation of the H2 phase. However, at pH
≥4.0, the gradual deprotonation of the 2OHOA molecules on
increasing pH resulted in electrostatic repulsions among its
deprotonated carboxyl-headgroups at the lipid−water interface.
This caused the swelling of the cubic Pn3m and Im3m phases
and eventually, at pH ≥4.5 the colloidal transformation from
cubosomes to vesicles.
The results contribute to the fundamental understanding of
the self-assembly of pH-responsive and surfactant-like lipids.
The presented experimental ﬁndings on the designed pH-
responsive 2OHOA/GMO nano-self-assemblies could guide
the development of advanced cancer nanomedicines for
targeted delivery of chemotherapeutics.
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